U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H8O2
Molecular Weight 136.1479
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZYL FORMATE

SMILES

O=COCC1=CC=CC=C1

InChI

InChIKey=UYWQUFXKFGHYNT-UHFFFAOYSA-N
InChI=1S/C8H8O2/c9-7-10-6-8-4-2-1-3-5-8/h1-5,7H,6H2

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Ionisations within a subtilisin-glyoxal inhibitor complex.
2005-05-20
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
2005-04-12
Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase/17,20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2.
2005-03
Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy.
2005-02
Asymmetric total syntheses of tuberostemonine, didehydrotuberostemonine, and 13-epituberostemonine.
2005-01-12
Purification and characterization of a high molecular mass serine carboxypeptidase from Monascus pilosus.
2004-12
Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
2004-12
In vitro-in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells.
2004-12
N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7.
2004-12
A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei.
2004-11-12
Chemoenzymatic preparation of optically active trans-cyclohexane-1,2-diamine derivatives: an efficient synthesis of the analgesic U-(-)-50,488.
2004-11-05
Factors controlling the complex architecture of native and modified cyclodextrins with dipeptide (Z-Glu-Tyr) studied by microcalorimetry and NMR spectroscopy: critical effects of peripheral bis-trimethylamination and cavity size.
2004-11-03
Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
2004-11
Carbamazepine enhances discriminative memory in a rat model of epilepsy.
2004-11
Fracture risk associated with use of antiepileptic drugs.
2004-11
Novel urea-linked cinchona-calixarene hybrid-type receptors for efficient chromatographic enantiomer separation of carbamate-protected cyclic amino acids.
2004-10-22
Subtype selective substrates for histone deacetylases.
2004-10-07
Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
2004-10
What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
2004-10
Microorganisms degrading chlorobenzene via a meta-cleavage pathway harbor highly similar chlorocatechol 2,3-dioxygenase-encoding gene clusters.
2004-10
Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
2004-09
Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism.
2004-08-27
[Influence of coadministered antiepileptic drugs on serum antiepileptic drug concentrations in epileptic patients -quantitative analysis based on suitable transforming factor].
2004-07
Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
2004-06
The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
2004-04
A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization.
2004-03-05
The sleep lipid oleamide may represent an endogenous anticonvulsant: an in vitro comparative study in the 4-aminopyridine rat brain-slice model.
2004-03
Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
2004-02-06
Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy.
2004-02
Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
2004-02
Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids.
2004-01
Pitch perception abnormality as a side effect of carbamazepine.
2004-01
Chronic carbamazepine treatment increases myristoylated alanine-rich C kinase substrate phosphorylation in the rat cerebral cortex via down-regulation of calcineurin A alpha.
2003-12-19
Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
2003-12
Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems.
2003-11
Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.
2003-09-15
Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier.
2003-09
Method for multiresidue determination of halogenated aromatics and PAHs in combustion-related samples.
2003-08-15
Simultaneous plasma lamotrigine analysis with carbamazepine, carbamazepine 10,11 epoxide, primidone, phenytoin, phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC).
2003-08-12
N-hydroxyethyl-piperidine and -pyrrolidine homoazasugars: preparation and evaluation of glycosidase inhibitory activity.
2003-07-31
Synthesis and reactions of fluorous carbobenzyloxy (FCbz) derivatives of alpha-amino acids.
2003-06-13
How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples?
2003-06
Bioaccumulation of PCBs and chlorinated pesticides in seals, fishes and invertebrates from the White Sea, Russia.
2003-05-01
Efficient protocols for the synthesis of enantiopure gamma-amino acids with proteinogenic side chains.
2003-05
Potassium trimethylsilanolate induced cleavage of 1,3-oxazolidin-2- and 5-ones, and application to the synthesis of (R)-salmeterol.
2003-04-07
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
2003-04
Chemical modification of lipases with various hydrophobic groups improves their enantioselectivity in hydrolytic reactions.
2003-01
Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules.
2003
An in vitro study of new antiepileptic drugs and astrocytes.
2003
Pharmacokinetic study of carbamazepine and its carbamazepine 10,11-epoxide metabolite in a group of female epileptic patients under chronic treatment.
2002-07-23
Patents
Name Type Language
BENZYL FORMATE
FCC   FHFI   MI  
Systematic Name English
FEMA NO. 2145
Preferred Name English
BENZYL FORMATE [FHFI]
Common Name English
FORMIC ACID, PHENYLMETHYL ESTER
Common Name English
BENZYL ALCOHOL, FORMATE
Systematic Name English
BENZYL METHANOATE
Systematic Name English
NSC-8049
Code English
FORMIC ACID, BENZYL ESTER
Common Name English
PHENYLMETHYL FORMATE
Systematic Name English
BENZYL FORMATE [FCC]
Common Name English
BENZYL FORMATE [MI]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 172.515
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
JECFA EVALUATION BENZYL FORMATE
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
Code System Code Type Description
FDA UNII
79GJF97O0Y
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
NSC
8049
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID5059298
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
PUBCHEM
7708
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
CAS
104-57-4
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-214-4
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
DRUG BANK
DB04569
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
JECFA MONOGRAPH
749
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY
MERCK INDEX
m2407
Created by admin on Mon Mar 31 18:40:40 GMT 2025 , Edited by admin on Mon Mar 31 18:40:40 GMT 2025
PRIMARY Merck Index